Recent study indicates that UHRF1 acts as an oncogene by silencing 8 selected TSGs in colon cancer cells through promoter hypermethylation of these TSGs and correlated with poor prognosis and the shortened overall survival rates (Kong et al. 2019). The gene discussed is UHRF1; the disease is colonic neoplasm.